About the webinar
This main objectives of this presentation are to:
1) Contrast bone disease in
Type 1 and Type 2 Diabetes
2) Identify risk factors for fracture in people with Type 1 and Type 2 diabetes;
3) Discuss the prevention and treatment of bone disease in people with diabetes.
Presenter
![thumbnail_20200221-Claudia_Gagnon_(_DSC2755)-Modifier thumbnail_20200221-Claudia_Gagnon_(_DSC2755)-Modifier](https://osteostrategy.on.ca/wp-content/uploads/bb-plugin/cache/thumbnail_20200221-Claudia_Gagnon__DSC2755-Modifier-150x150-circle-ea236f73f0a8fe00e8b24010d3acff62-dk36mcwvpg40.jpg)
DR. CLAUDIA GAGNON
Associate Professor in the Department of Medicine Université Laval
Clinician-researcher scholar of the Fonds de recherche en santé du Québec
Researcher at CHU de Québec-Université Laval Research Centre and at Québec Heart and Lung Institute Research Centre in Québec City
Vice-Chair of the Scientific Advisory Council of Osteoporosis Canada since September 2021